Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,780 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $230.61 | 3 | $0 (2024) |
| Lilly USA, LLC | $230.55 | 4 | $0 (2019) |
| GENZYME CORPORATION | $201.60 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $170.97 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $125.00 | 1 | $0 (2017) |
| PFIZER INC. | $125.00 | 1 | $0 (2017) |
| Kite Pharma, Inc. | $122.09 | 1 | $0 (2024) |
| Foundation Medicine, Inc. | $119.62 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $117.84 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $91.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $400.69 | 4 | Kite Pharma, Inc. ($122.09) |
| 2023 | $305.82 | 3 | E.R. Squibb & Sons, L.L.C. ($128.05) |
| 2019 | $118.25 | 3 | Regeneron Pharmaceuticals, Inc. ($83.89) |
| 2018 | $495.08 | 6 | Lilly USA, LLC ($214.55) |
| 2017 | $460.62 | 4 | Novartis Pharmaceuticals Corporation ($125.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $84.20 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: CELLT | ||||||
| 05/15/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: Oncology | ||||||
| 04/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $93.60 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Incyte Corporation | JAKAFI (Drug), MONJUVI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $76.97 | General |
| Category: Hematology/Oncology | ||||||
| 09/14/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: Oncology | ||||||
| 03/15/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $128.05 | General |
| 09/11/2019 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $83.89 | General |
| 08/02/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| 06/01/2019 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 12/11/2018 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $87.41 | General |
| Category: Oncology | ||||||
| 11/20/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Xofigo | Food and Beverage | In-kind items and services | $77.37 | General |
| Category: Oncology | ||||||
| 11/12/2018 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $85.32 | General |
| Category: None | ||||||
| 09/27/2018 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $52.29 | General |
| Category: Oncology | ||||||
| 06/02/2018 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $74.85 | General |
| 01/03/2018 | Janssen Scientific Affairs, LLC | YONDELIS (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $117.84 | General |
| Category: Oncology | ||||||
| 08/31/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $119.62 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $91.00 | General |
| Category: Immunology | ||||||
| 02/08/2017 | Novartis Pharmaceuticals Corporation | BYL719 (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/01/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 171 | 717 | $286,656 | $57,892 |
| 2022 | 2 | 126 | 417 | $152,327 | $34,962 |
| 2021 | 4 | 108 | 329 | $96,091 | $27,105 |
| 2020 | 2 | 40 | 124 | $27,873 | $8,451 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 111 | 553 | $199,080 | $40,120 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 60 | 164 | $87,576 | $17,772 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 77 | 320 | $103,875 | $23,972 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 49 | 97 | $48,452 | $10,989 | 22.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 165 | $57,915 | $13,525 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 47 | 125 | $26,125 | $9,468 | 36.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 25 | $7,375 | $2,933 | 39.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 14 | 14 | $4,676 | $1,179 | 25.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 29 | 102 | $21,383 | $6,458 | 30.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 11 | 22 | $6,490 | $1,992 | 30.7% |
About Dr. Raymond Hohl, MD
Dr. Raymond Hohl, MD is a Hematology & Oncology healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710975651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raymond Hohl, MD has received a total of $1,780 in payments from pharmaceutical and medical device companies, with $400.69 received in 2024. These payments were reported across 20 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,780).
As a Medicare-enrolled provider, Hohl has provided services to 445 Medicare beneficiaries, totaling 1,587 services with total Medicare billing of $128,409. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Hershey, PA
- Active Since 10/13/2005
- Last Updated 07/21/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1710975651
Products in Payments
- SARCLISA (Biological) $201.60
- CYRAMZA (Drug) $139.70
- BYL719 (Drug) $125.00
- Yescarta (Drug) $122.09
- FOUNDATIONONE (Device) $119.62
- YONDELIS (Drug) $117.84
- Nubeqa (Drug) $93.60
- SOLIRIS (Drug) $91.00
- Non-Covered Product (Drug) $85.32
- OPDIVO (Biological) $84.20
- Stivarga (Drug) $77.37
- JAKAFI (Drug) $76.97
- VERZENIO (Drug) $16.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Hershey
Dr. Kevin Rakszawski, M.d, M.D
Hematology & Oncology — Payments: $221,742
Jeffrey Pu, M.d, M.D
Hematology & Oncology — Payments: $205,003
Dr. Cristina Truica, M.d, M.D
Hematology & Oncology — Payments: $107,088
Patrick Ma, Md, MD
Hematology & Oncology — Payments: $99,479
Joseph Drabick, Md, MD
Hematology & Oncology — Payments: $54,854
Witold Rybka, Md, MD
Hematology & Oncology — Payments: $31,971